We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03087708
Recruitment Status : Recruiting
First Posted : March 22, 2017
Last Update Posted : October 18, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : April 2019
  Estimated Study Completion Date : October 2020